Murphy Edward L. reported option exercise involving 1,695 derivative units of Co-Diagnostics, Inc. at $0.00 for $0 on May 23, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed May 27, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
1,695Restricted Stock Unit
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
4,000Direct
Trade date
May 23, 2026Option exercise
Filed
May 27, 2026, 4:03 PM ET4-day reporting delay
Accession
0001794564-26-000002Code M · Transaction 91538
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 23, 2026Grant1,695$0.00$0Trade 91536
2 transaction rows in this filing. Joint filers share the same rows.

CODX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CODX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −77%1w ago −82%1d ago −31%
Returns since7d −29%30d −58%90d −83%180d1y

Footnotes in full

F1: Included in 2,334 restricted stock units awarded to the Reporting Person on June 12, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2023. Included in 3,667 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2024. Included in 4,167 restricted stock units awarded to the Reporting Person on August 13, 2025, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2025.